JLE

Bulletin du Cancer

MENU

Translational research and Cancer Plan Volume 94, issue 12, décembre 2007

Figures

See all figures

Authors
Cancéropôle Ile-de-France, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75475 Paris Cedex 10, Institut national du cancer, 52, avenue André-Morizet, 92513 Boulogne-Billancourt Cedex, Servier, 125 chemin de Ronde, 78290 Croissy-sur-Seine, Sanofi-Aventis, Sanofi-Aventis recherche & développement, 371, rue du Professeur Joseph-Blayac, 34184 Montpellier Cedex 04, Cancéropôle Grand Ouest, CHU, Maison de la recherche en santé, 5, allée de l’Ile-Gloriette, 44093 Nantes Cedex 1, Cancéropôle Nord Ouest, BP 90005, 59008 Lille Cedex, Cancéropôle CLARA, 60, avenue Rockfeller, 69008 Lyon, Inserm, 101, rue de Tolbiac, 75654 Paris Cedex 13, Janssen-Cilag, Campus de Maigremont, BP 615, 27106 Val-de-Reuil Cedex, Janssen-Cilag, TSA 91003, 92787 Issy-les-Moulineaux Cedex 9, Novartis, 2-4 rue Lionel-Terray, BP 308, 92506 Rueil-Malmaison Cedex, Bristol Myers Squibb, 3 rue Joseph-Monier, 92500 Rueil-Malmaison, Astra Zeneca, 1 place Renault, 92844 Rueil-Malmaison Cedex, Amgen, 62, boulevard Victor-Hugo, 92523 Neuilly-sur-Seine Cedex, Cancéropôle Grand Est, hôpital de Hautepierre, 1 avenue Molière, 67098 Strasbourg Cedex, Leem Recherche, 25 rue de Montévidéo, 75116 Paris

The French Cancer Plan 2003-2007 has made translational research central to its research programme, to ensure the care-research continuum and the quickest application possible for the most recent discoveries, for the patients’ benefit. This is a new field of research, still little-known or ill-understood. A working group, composed of physicians and researchers from academic research and industrial research, sought to define translational research in cancerology and define the issues at stake in it. Translational research needs to develop in close connection with the patients in order to enable a bi-directional flow of knowledge from cognitive research toward medical applications and from observations made on patients toward cognitive research. Placed under the aegis of the French National Cancer Institute and Leem Research, the group has put forth a strategy for implementing translational research in cancerology in France to make it attractive, competitive and efficient and to foster the development of public-private partnerships.